In Burundi, a silent killer has long cast a shadow over families and communities: cervical cancer. For too long, this devastating disease, which, tragically, is almost entirely preventable, has claimed countless lives. But recently, a beacon of hope emerged. On April 29th, Burundi embarked on a nationwide mission to introduce the human papillomavirus (HPV) vaccine, a powerful shield against cervical cancer. For those dedicated health workers across the country, it was a race against time, a passionate effort to share vital information and empower communities with knowledge. Despite the insidious whispers of misinformation that attempted to derail their efforts, their determination paid off in a remarkable way. According to the Ministry, an overwhelming 84.4% of the target population received the vaccine during the initial three-day campaign, a testament to the power of education and trust.
Emelyne Ngiriyabandi, a resilient 46-year-old mother from Kibimba village, perfectly encapsulates the journey of so many Burundians. Until health workers arrived at her doorstep in early April, she had never even heard of cervical cancer. The conversation that followed was a revelation, shattering her perception of unexplained illnesses. “When they told us about the signs and symptoms, my heart sunk,” Emelyne recalled, her voice heavy with a newfound understanding. “I do believe many of our neighbors died of this disease without knowing.” This heartbreaking realization fueled her resolve, leading her to witness her two adolescent daughters receive the life-saving vaccine during its national launch a few weeks later. The relief in her eyes was palpable as she explained, “Despite not having known this disease two weeks ago, I managed to sit and talk to my girls about the benefits because I trust our leaders who told us it is safe.” This trust was undoubtedly bolstered by the visible support of figures like First Lady Angeline Ndayishimiye, who courageously urged parents to reject misinformation “with contempt.”
The gravity of cervical cancer in Burundi cannot be overstated. It is not only the most common cancer but also the most deadly, claiming over 1,000 lives annually, a staggering 18.8% of all cancer deaths in the country, according to the World Health Organization (WHO). For years, a lack of awareness and screening rates below 10% meant that diagnoses often came too late, leaving families grappling with unimaginable loss. However, with the introduction of the one-dose HPV vaccine, a lifetime shield against the disease, the future for girls like Emelyne’s daughters looks dramatically different. Dr. Marthe Sylvie Essengue Elouma, Director of Priority Countries at Gavi, highlighted the powerful scientific evidence behind this hope, citing studies that show an 87% reduction in cervical cancer risk in vaccinated women. Further reinforcing this, a 2023 WHO study by the International Agency for Research on Cancer (IARC) revealed an astounding statistic from neighboring Rwanda: HPV vaccination had more than halved the prevalence of high-risk HPV types in less than eight years. This compelling data paints a clear picture: the HPV vaccine is a game-changer, a crucial tool in turning the tide against cervical cancer.
Despite the compelling evidence and the widespread success of the initial vaccination campaign, the battle against misinformation continues. Emelyne herself observed with concern that some parents were still hiding their children to avoid vaccination, often swayed by unfounded fears. “In most cases it is because of the misinformation and lack of awareness,” she explained, specifically highlighting the pervasive and erroneous belief that the HPV vaccine causes infertility. This deeply rooted misconception, utterly contradicted by years of scientific evidence and successful vaccination programs worldwide, unfortunately led to instances like 80 students from one primary school “fleeing under the influence of certain religious beliefs.” Dr. Polycarpe Ndayikeza, the spokesperson for the Burundian health ministry, acknowledged this challenge and stressed the government’s proactive approach. Working closely with local administrative authorities and community leaders, they are actively combating misinformation through direct outreach programs in schools and communities. While still in its early stages, Dr. Ndayikeza mentioned exploring digital strategies, including the use of WhatsApp or SMS, to further disseminate accurate information and reassure the public. However, health workers like Inarukundo Anitha and teachers like Sibomana Maria Goreth understand that the fight against misinformation is an ongoing commitment, essential to ensure every girl has an equal opportunity for a cervical cancer-free future.
The profound impact of the HPV vaccine isn’t just a future promise; for some, it’s a lived reality. Lyse Raïssa Dukeze, now a 23-year-old mother, offers a poignant and powerful testament to this. Back in 2018, as a then 14-year-old, she was part of a vanguard group of 12,000 Burundian girls who participated in a pilot HPV vaccination project. Her decision to get vaccinated was deeply personal: “Before I received the vaccine, my aunt had died of cervical cancer. I witnessed her suffering and it is because of that I decided to get vaccinated.” It was a decision she’s profoundly grateful for, especially in the face of the same misinformation that still plagues communities today. “During that period there was a lot of misinformation – they said that if vaccinated, you will never give birth,” Lyse shared, a triumphant smile hinting at her proof. “But I was vaccinated, and today I have a child. I feel safe now.” Lyse’s story is a living, breathing testament to the vaccine’s safety and effectiveness, a powerful counter-narrative to the unfounded fears.
The overwhelming success of the April-May launch campaign, with 84.4% of the target population vaccinated, underscores the immense desire among Burundian girls to protect their future. Giraneza Darlene, a 13-year-old student at Kibimba Primary School, was among those who eagerly received the vaccine. Her words resonate with a newfound sense of security: “They told us about the disease and we felt like it was the right time we got vaccinated. I feel safe now and I had no hesitation in taking the jab.” This widespread acceptance has paved the way for a crucial step: the HPV vaccine has now been integrated into Burundi’s routine immunization schedule, making it freely available to girls aged 9–14 across all vaccination centers nationwide. This crucial development brings Burundi closer to a shared global vision, articulated by Gavi’s Elouma, to vaccinate 90% of girls before the age of 15, screen 70% of women, and treat 90% of those diagnosed before 2030. Burundi’s journey, from a nation grappling with a silent killer to one embracing a future free from cervical cancer, stands as a powerful testament to the impact of collective action, scientific innovation, and unwavering human spirit.